English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Despite enormous progress over the past few decades in reducing deaths from cardiovascular disease, the ability to identify patients at risk for sudden cardiac death (SCD) remains a challenge. SCD accounts for about 350,000 deaths annually in the United States (1). Most SCDs are from ventricular arrhythmias—ventricular tachycardia and ventricular fibrillation (VT/VF)— and the means to effectively identify patients before such an event, although improving, are still limited. The question is whether a simple, noninvasive test such as radionuclide imaging with

A Potential Key Role for Radionuclide Imaging in the Prediction and Prevention of Sudden Arrhythmic Cardiac Death